Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
About this item
Full title
Author / Creator
Meissner, Eric G. , Wu, David , Osinusi, Anu , Bon, Dimitra , Virtaneva, Kimmo , Sturdevant, Dan , Porcella, Steve , Wang, Honghui , Herrmann, Eva , McHutchison, John , Suffredini, Anthony F. , Polis, Michael , Hewitt, Stephen , Prokunina-Olsson, Ludmila , Masur, Henry , Fauci, Anthony S. and Kottilil, Shyamasundaran
Publisher
United States: American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
BACKGROUND. Hepatitis C virus (HCV) infects approximately 170 million people worldwide and may lead to cirrhosis and hepatocellular carcinoma in chronically infected individuals. Treatment is rapidly evolving from IFN-α-based therapies to IFN-α-free regimens that consist of directly acting antiviral agents (DAAs), which demonstrate improved efficac...
Alternative Titles
Full title
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4109554
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4109554
Other Identifiers
ISSN
0021-9738,1558-8238
E-ISSN
1558-8238
DOI
10.1172/JCI75938
